It's a tragic condemnation of the way we do health and nutrition that if no one profits from marketing and selling something, the masses typically won't hear about the benefits of it.
It's a tragic condemnation of the way we do health and nutrition that if no one profits from marketing and selling something, the masses typically won't hear about the benefits of it.
http://slatestarcodex.com/2014/06/15/fish-now-by-prescriptio...
If a website can pin something on Big Pharma, well, it must be true, because a huge increase in click-through revenue doesn't lie.
EDIT: this is another example of the "fact rule" -- if you post something factual and uncontroversial, you will be downvoted with a probability of 1.
BTW: There is indeed an annoying level of unnecessary downvoting going on.
Really, it's a horrible argument. It presupposes that everyone working for Big Pharma is a sociopath who only cares about the next quarterly report.
The problem should be obvious -- lithium is an element that cannot be protected by trademark, patent or copyright. Anyone marketing it is sure to be undercut as soon as the product begins to win public acceptance and show a profit.
The other issue is toxicity. Without professional advice, people might think that, because a small amount confers benefit, therefore more is better. But, not unlike vitamin A, lithium becomes toxic above relatively low levels. For that reason it's not likely to be sold over the counter.
Also, the article talked about the benefits of consuming lithium at a tiny fraction of the therapeutic level. There are plenty of legal, common supplements that are similarly toxic if consumed in those amounts.
One can make money selling vitamin C - after someone (such as the government) has spent a lot of money running experiments and publishing the results, yielding a public good of the knowledge 'vitamin C may be good for some things'.
One will have a much more difficult time making money by investing in research establishing 'substance X is good for something', publishing that information, and then selling substance X - when substance X is cheap, widely available, and one's competitors will instantly match and undercut any of your offerings of X.